| Systematic (IUPAC) name | |
|---|---|
| N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | topical |
| Identifiers | |
| CAS number | 129639-79-8 |
| ATC code | None |
| PubChem | CID 159326 |
| ChemSpider | 140124 |
| UNII | 11DI31LWXF |
| Chemical data | |
| Formula | C21H22N4OS |
| Mol. mass | 378.491 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Abafungin (INN) is a broad-spectrum antifungal agent with a novel mechanism of action for the treatment of dermatomycoses.
Abasol is a topical cream formulation of abafungin by York Pharma.[1]
Like imidazole- and triazole-class antifungals, abafungin inhibits the fungal cytochrome P450 enzyme 14α-demethylase. This inhibition prevents the conversion of lanosterol to ergosterol, an essential component of the fungal cytoplasmic membrane.
In addition, abafungin inhibits the enzyme sterol 24-C-methyltransferase, modifying the composition of the fungal membrane.
Abafungin has antibiotic activity against gram-positive bacteria as well as sporicidal activity.[2]
|
||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)